Genetic Variation and Mutation Types

Genetic variation is the raw material of heredity and disease: differences in DNA sequence between individuals that range from the change of a single base to the gain or loss of whole chromosome segments. This area surveys the principal types of mutation by mechanism and scale, from point mutations through structural and copy-number changes, and the conventions used to describe and interpret them clinically.

Definition

A mutation is a heritable change in the nucleotide sequence of the genome; mutation types are categories of such change defined by their molecular mechanism (e.g., base substitution, insertion/deletion, rearrangement) and by their scale (single nucleotide, exon, gene, chromosome segment).

Scope

The area orients the reader to how DNA-sequence changes are classified and named, organising its topics by molecular scale and consequence: point mutations and missense variants; nonsense and frameshift mutations; splice-site mutations; chromosomal structural variations; and copy number variation. It treats these as reference concepts in medical genetics and the standards (HGVS nomenclature, ACMG/AMP interpretation) used to describe them, not as clinical management guidance.

Sub-topics

• Chromosomal Structural Variations
• Copy Number Variation
• Nonsense and Frameshift Mutations
• Point Mutations and Missense Variants
• Splice-Site Mutations

Key concepts

• Point mutation (substitution)
• Insertion and deletion (indel)
• Reading frame and frameshift
• Coding versus non-coding change
• Structural variation
• Copy number variation
• De novo versus inherited variant
• Pathogenicity and variant classification (ACMG/AMP)
• HGVS sequence-variant nomenclature

Mechanisms

Mutations arise from errors in DNA replication and repair, recombination, and exposure to mutagens. They are grouped by scale: small-scale sequence changes (single-base substitutions and small insertions or deletions) alter or shift codons and can change, truncate, or abolish a protein; splice-site changes disrupt the signals that define exon boundaries; and large-scale structural changes (deletions, duplications, inversions, translocations) and copy number variations reorganise or alter the dosage of larger genomic segments. Interpreting whether a given variant is benign or disease-causing rests on standardised frameworks such as the ACMG/AMP criteria, while consistent description relies on HGVS nomenclature.

Clinical relevance

Mutation type shapes how a variant is investigated and reported in clinical genetics: small sequence variants, structural rearrangements, and copy number changes are detected by different assays and weighed by different interpretive criteria. Understanding these categories supports critical reading of genetic test reports and the literature; this area describes how variation is classified and named and is not a basis for individual diagnostic or treatment decisions.

Evidence & guidelines

Consistent variant description follows the HGVS recommendations (den Dunnen et al., 2016), and clinical interpretation of sequence variants is widely guided by the ACMG/AMP consensus framework (Richards et al., 2015), which grades evidence toward five categories from benign to pathogenic.

Seminal works

• richards-2015
• dendunnen-2016
• feuk-2006

Frequently asked questions

How are mutation types categorised?

Primarily by molecular mechanism and scale: single-base substitutions (including missense and nonsense), small insertions and deletions (which may cause frameshifts), splice-site changes, larger structural rearrangements, and copy number variation that alters the dosage of genomic segments.

What is the difference between a variant and a mutation?

Both refer to a difference from a reference sequence. Current practice often prefers the neutral term variant for any such difference and reserves clinical significance (benign to pathogenic) for a separate, evidence-based classification step such as the ACMG/AMP framework.